lobbying_activities: 826173

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
826173	b2e06add-0a40-4ef4-955d-20800a6d8c19	Q3	BALCH & BINGHAM, LLP	5197	VAXIN PHARMACEUTICALS INC	2009	third_quarter	MED	Funding for Immunocontraceptive vaccines through Department of Interior, Agriculture or Transportation Appropriations bills; in ovo vaccination by recombinant adenovirus vectors through Department of Agriculture or Homeland Security Appropriations bills; non-invasive vectored vaccine research through Department of Defense Authorization or Defense Appropriations bills.	HOUSE OF REPRESENTATIVES,SENATE			0	0	2009-10-13T15:55:40-04:00